Covered recipient · General Payments record
ERIC WAYNE BECK
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$2,658.02
- Reported across 156 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $538.99 | 30 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $227.37 | 13 |
| Lilly USA, LLC | $163.78 | 9 |
| ABBVIE INC. | $37.67 | 2 |
| INTRA-SANA LABORATORIES | $26.42 | 1 |
| GlaxoSmithKline, LLC. | $20.24 | 1 |
| PFIZER INC. | $17.61 | 1 |
| Azurity Pharmaceuticals, Inc. | $17.08 | 1 |
| Sumitomo Pharma America, Inc. | $15.50 | 1 |
| Phadia US Inc. | $13.32 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (30)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $23.92 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103297084 | CMS |
| ABBVIE INC. | $13.75 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103297086 | CMS |
| Azurity Pharmaceuticals, Inc. | $17.08 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134003141 | CMS |
| GlaxoSmithKline, LLC. | $20.24 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116162619 | CMS |
| Intra-Sana Laboratories | $26.42 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138617079 | CMS |
| Lilly USA, LLC | $18.86 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136163354 | CMS |
| Lilly USA, LLC | $20.07 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134967979 | CMS |
| Lilly USA, LLC | $15.86 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134973811 | CMS |
| Lilly USA, LLC | $19.49 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136163356 | CMS |
| Lilly USA, LLC | $19.76 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136168581 | CMS |
| Lilly USA, LLC | $20.90 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136163358 | CMS |
| Lilly USA, LLC | $13.39 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134973463 | CMS |
| Lilly USA, LLC | $16.67 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134967821 | CMS |
| Lilly USA, LLC | $18.78 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134973809 | CMS |
| Novo Nordisk Inc | $17.00 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097354828 | CMS |
| Novo Nordisk Inc | $20.95 | 02/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096934781 | CMS |
| Novo Nordisk Inc | $19.96 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097476987 | CMS |
| Novo Nordisk Inc | $12.28 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097145529 | CMS |
| Novo Nordisk Inc | $15.98 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097391383 | CMS |
| Novo Nordisk Inc | $20.72 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097262675 | CMS |
| Novo Nordisk Inc | $20.01 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097386627 | CMS |
| Novo Nordisk Inc | $21.46 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097250054 | CMS |
| Novo Nordisk Inc | $21.60 | 09/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096900611 | CMS |
| Novo Nordisk Inc | $16.71 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097151603 | CMS |
| Novo Nordisk Inc | $9.19 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096898587 | CMS |
| Novo Nordisk Inc | $10.97 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097303563 | CMS |
| Novo Nordisk Inc | $20.54 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097045537 | CMS |
| PFIZER INC. | $17.61 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131247922 | CMS |
| Phadia US Inc. | $13.32 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1067578588 | CMS |
| Sumitomo Pharma America, Inc. | $15.50 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148825932 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.